JAM-A/CD321 Rekombinanter Antikörper

JAM-A/CD321 Rekombinant Antikörper für FC

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

Maus

Anwendung

FC

Konjugation

Unkonjugiert

CloneNo.

250060G10

Kat-Nr. : 98516-2-RR

Synonyme

CD321, F11r, Jam1, JAM-1, JAM-A

---

• 

  FC experiment of mouse peripheral blood platelets using 98516-2-RR

  1x10^6 mouse peripheral blood platelets were surface stained with 0.25 ug Anti-Mouse JAM-A/CD321 Rabbit RecAb (98516-2-RR, Clone: 250060G10) or 0.25 ug Rabbit IgG Isotype Control RecAb (98136-1-RR, Clone: 240953C9) (blue), and PE-Conjugated Goat Anti-Rabbit IgG(H+L)(red). Cells were not fixed.

---

Geprüfte Anwendungen

• Erfolgreiche Detektion in FC: mouse peripheral blood platelets

Empfohlene Verdünnung

Anwendung	Verdünnung
This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Produktinformation

98516-2-RR bindet in FC JAM-A/CD321 und zeigt Reaktivität mit Maus

• Getestete Reaktivität: Maus
• Wirt / Isotyp: Kaninchen / IgG
• Klonalität: Rekombinant
• Typ: Antikörper
• Immunogen: JAM-A/CD321 fusion protein Eg3117
• Vollständiger Name: F11 receptor
• Berechnetes Molekulargewicht: 32 kDa
• GenBank-Zugangsnummer: NM_172647.2
• Gene symbol: F11r
• Gene ID (NCBI): 16456
• Konjugation: Unkonjugiert
• Form: Liquid
• Reinigungsmethode: Protein-A-Reinigung
• Lagerungspuffer: PBS with 0.09% sodium azide
• Lagerungsbedingungen: Store at 2 - 8°C. Stable for one year after shipment.

Hintergrundinformationen

Junctional adhesion molecule A (JAM-A), also known as CD321 or F11 receptor (F11R), is a transmembrane protein that belongs to the immunoglobulin superfamily of cell adhesion molecules. JAM-A is present in epithelial cells, endothelial cells, leukocytes, and blood platelets. JAM-A participates in regulating various biological processes, as diverse as paracellular permeability, tight junction formation and maintenance, leukocyte transendothelial migration, epithelial-to-mesenchymal transition, angiogenesis, reovirus binding, and platelet activation.